Skip to main content
. Author manuscript; available in PMC: 2007 Nov 29.
Published in final edited form as: Brain Res. 2006 Oct 24;1122(1):143–153. doi: 10.1016/j.brainres.2006.08.127

Fig. 5.

Fig. 5

Individual examples of BC inactivation effects on CR performance when 2 μl of TTX were injected at progressively shorter distances from the BC. Each column represents a complete printout of eyeblink records in one experiment, with the first trial at the top and the last trial at the bottom of each stack. The first 40 trials (above the wide gap) represent normal CR incidence before the injection. The remaining trials (below the gap) cover 70 min following the TTX injection. Injecting TTX had no effect on CR performance at 1.7 mm dorsal to the BC (A). Injections at 1.2 mm (B) and 0.9 mm (C) partially abolished CRs, with effects on CR incidence, latency and amplitude. Only the deepest injection, 0.6 mm dorsal to the BC (D) completely abolished CRs. CS – conditioned stimulus onset. US – unconditioned stimulus onset.